oxazolidin-2-one has been researched along with carbostyril in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (57.89) | 29.6817 |
2010's | 7 (36.84) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Hubschwerlen, C; Locher, HH; Schroeder, S; Sigwalt, C; Specklin, JL | 1 |
Banitt, LS; Barbachyn, MR; Evans, JM; Gage, JR; Gomez, M; Gordeev, MF; Hackbarth, C; Luehr, GW; Morin, SE; Parker, CN; Patel, DV; Trias, J; White, RJ; Zurenko, GE | 1 |
Baeschlin, DK; Borer, Y; Haefeli, S; Hubschwerlen, C; Locher, HH; Schroeder, S; Sigwalt, C; Specklin, JL | 1 |
Choi, SH; Gonzalez, G; Ochoa-Felix, EY; Tijerina, R; Vera-Cabrera, L; Welsh, O | 1 |
Schweiger, ES; Weinberg, JM | 1 |
Gospodarek, E; Mikucka, A; Zalas, P | 1 |
Bolaños, M; Finegold, SM; Molitoris, D; Väisänen, ML | 1 |
Appelbaum, PC; Bogdanovich, T; Ednie, LM; Jones, RN; Kosowska-Shick, K; Smith, K | 1 |
Appelbaum, PC; Credito, K; Lin, G | 1 |
Abbanat, D; Bush, K; Morrow, B | 1 |
Phillips, OA; Sharaf, LH | 1 |
Medico, CJ; Walsh, P | 1 |
Leggio, M; Podos, SD; Pucci, MJ; Thanassi, JA | 1 |
Karpiuk, I; Tyski, S | 1 |
Bäckström, T; Björkhem-Bergman, L; Dalhoff, A; Nord, CE; Panagiotidis, G; Rashid, MU; Weintraub, A | 1 |
Keum, YS; Park, SW; Patel, RV | 1 |
Freeman, J; Pilling, S; Vernon, J; Wilcox, MH | 1 |
Guo, L; Liu, Y; Sun, J; Zhang, J; Zhang, Y | 1 |
Goto, K; Itoh, H; Kai, M; Kitano, T; Ohchi, Y; Suzuki, Y; Tanaka, R; Tatsuta, R; Yasuda, N | 1 |
4 review(s) available for oxazolidin-2-one and carbostyril
Article | Year |
---|---|
Novel antibacterial agents for skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Oxazolidinones; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections; Virginiamycin | 2004 |
New agents in development for the treatment of bacterial infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Glycopeptides; Humans; Macrolides; Oxazolidinones; Quinolones | 2008 |
Pharmacotherapy in the critically ill obese patient.
Topics: Aminoglycosides; Antithrombins; Arginine; Body Mass Index; Carbapenems; Cephalosporins; Drug Dosage Calculations; Enoxaparin; Fibrinolytic Agents; Heparin; Humans; Hypnotics and Sedatives; Lipopeptides; Obesity; Oxazolidinones; Penicillins; Pipecolic Acids; Protein C; Quinolones; Recombinant Proteins; Safety; Sulfonamides; Vancomycin | 2010 |
Nitroimidazoles, Quinolones and Oxazolidinones as Fluorine Bearing Antitubercular Clinical Candidates.
Topics: Animals; Antitubercular Agents; Drug Discovery; Fluorine; Humans; Nitroimidazoles; Oxazolidinones; Quinolones; Tuberculosis | 2015 |
15 other study(ies) available for oxazolidin-2-one and carbostyril
Article | Year |
---|---|
Design, synthesis and biological evaluation of oxazolidinone-quinolone hybrids.
Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Protein Biosynthesis; Quinolones; Structure-Activity Relationship; Transcription, Genetic | 2003 |
Novel oxazolidinone-quinolone hybrid antimicrobials.
Topics: Acetamides; Anti-Bacterial Agents; Ciprofloxacin; DNA Topoisomerase IV; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Quinolones; Structure-Activity Relationship | 2003 |
Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action.
Topics: Acetamides; Anti-Bacterial Agents; DNA Topoisomerase IV; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Quinolones; Structure-Activity Relationship | 2003 |
In vitro activities of new quinolones and oxazolidinones against Actinomadura madurae.
Topics: Anti-Infective Agents; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxazolidinones; Quinolones; Skin Diseases, Infectious | 2004 |
[Antibiotic sensitivity of Corynebacterium amycolatum].
Topics: Acetamides; Anti-Bacterial Agents; beta-Lactams; Corynebacterium; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Lincosamides; Linezolid; Macrolides; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Quinolones; Virginiamycin | 2004 |
In vitro activities of DX-619 and four comparator agents against 376 anaerobic bacterial isolates.
Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Fluoroquinolones; Humans; In Vitro Techniques; Inhibitory Concentration 50; Linezolid; Meropenem; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Oxazolidinones; Pyrrolidines; Quinolines; Quinolones; Thienamycins | 2006 |
Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominis.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; beta-Lactams; Cardiobacterium; Drug Resistance, Bacterial; Glycolipids; Ketolides; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Pyrrolidines; Quinolones; Streptococcus bovis; Viridans Streptococci | 2006 |
Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing.
Topics: Acetamides; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Pyrrolidines; Quinolones; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2007 |
5-Hydroxymethyl-oxazolidin-2-one antibacterials. Actelion Pharmaceuticals: WO2008062379.
Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA Topoisomerase IV; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Oxazolidinones; Patents as Topic; Quinolones | 2009 |
Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Biofilms; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Oxazolidinones; Quinolines; Quinolones; Rifampin; Staphylococcus; Thiazoles; Vancomycin | 2012 |
[Looking for the new preparations for antibacterial therapy. I. New antibiotics and chemotherapeutics on the market].
Topics: Anti-Bacterial Agents; Diterpenes; Drug Resistance, Bacterial; Drugs, Investigational; Humans; Lipopeptides; Oxazolidinones; Pleuromutilins; Polycyclic Compounds; Quinolones | 2012 |
Ecological impact of MCB3837 on the normal human microbiota.
Topics: Anti-Bacterial Agents; Bacteria; Candida; Gastrointestinal Tract; Healthy Volunteers; Humans; Male; Microbiological Techniques; Microbiota; Nasal Cavity; Oropharynx; Oxazolidinones; Prodrugs; Quinolones; Skin; Time Factors | 2014 |
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Polymerase Chain Reaction; Pyrrolidines; Quinolones; Ribotyping | 2017 |
Enzyme Inhibitor Antibiotics and Antibiotic-Associated Diarrhea in Critically Ill Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; China; Critical Illness; Diarrhea; Enzyme Inhibitors; Female; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Oxazolidinones; Quinolones; Retrospective Studies | 2018 |
Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Azoles; Carbapenems; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Doripenem; Drug Monitoring; Female; Fluconazole; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Linezolid; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazines; Oxazolidinones; Quinolones; Tandem Mass Spectrometry; Tetrazoles; Voriconazole | 2021 |